SCHEMBL755641

SCHEMBL755641

Brc1c[nH]c2nccc-2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IMPDH2 P12268 1/20 0.39
IDO1 P14902 2/20 0.37
NISCH Q9Y2I1 2/20 0.36
MTOR P42345 1/20 0.36
ADK P55263 1/20 0.36
ALDH1A1 P00352 3/20 0.34
KDM4E B2RXH2 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
DCUN1D1 Q96GG9 2/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
ALOX12 P18054 1/20 0.33
MPI P34949 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CCNB2 O95067 1/20 0.33
CDK1 P06493 1/20 0.33
CCNB1 P14635 1/20 0.33
PRKACA P17612 1/20 0.33
PRKACG P22612 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29754089 0.98 IMPDH2 (0.38) IMPDH2IDO1NISCHMTORADK
SCHEMBL25478238 0.71 NISCH (0.35) NISCHMTORADKGSK3BCDK5
SCHEMBL5597961 0.71 NTRK1 (0.42) NISCHMTORADKALDH1A1KDM4E
SCHEMBL31333987 0.71 NISCH (0.60) IDO1NISCHMTORADKALDH1A1
SCHEMBL1688497 0.71 NISCH (0.60) IDO1NISCHMTORADKALDH1A1
SCHEMBL28728517 0.68 NISCH (0.52) NISCHMTORADKALDH1A1KDM4E
SCHEMBL5598015 0.65 NISCH (0.31) NISCH
Pyrimidine SCHEMBL28016982 0.65 NISCH (0.51) IDO1NISCHMTORADKALDH1A1
SCHEMBL7698513 0.64 NISCH (0.52) NISCHMTORADKALDH1A1KDM4E
SCHEMBL27767101 0.64 NISCH (0.52) IDO1NISCHMTORADKALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250243181-A2 NOVEL INDAZOLE DERIVATIVE AND USE THEREOF KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2025-07-31 US disclosed
CN-114867718-B Indazole derivatives and use thereof 韩国化学研究院 2024-10-01 CN disclosed
US-20230116733-A1 NOVEL INDAZOLE DERIVATIVE AND USE THEREOF KOREA RESEARCH INSTITUTE OFCHEMICAL TECHNOLOGY (KR) 2023-04-13 US disclosed
EP-4079732-A1 NOVEL INDAZOLE DERIVATIVE, AND USE THEREOF Korea Research Institute of Chemical Technology (KR) 2022-10-26 EP disclosed
CN-114867718-A Novel indazole derivative and use thereof 韩国化学研究院 2022-08-05 CN disclosed
WO-2021125802-A1 NOVEL INDAZOLE DERIVATIVE, AND USE THEREOF 한국화학연구원 2021-06-24 WO disclosed
EP-2430031-A1 1,2,4-TRIAZOLO[4,3-A]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS Janssen Pharmaceuticals Inc. (US) 2012-03-21 EP disclosed
WO-2010130422-A1 1,2,4-TRIAZOLO[4,3-A]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC (US) 2010-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250243181-A2 NOVEL INDAZOLE DERIVATIVE AND USE THEREOF TRIB2, YAP1, IDO2 IMPDH2 2393/4885IDO1 9/4885NISCH 4431/4885
US-20230116733-A1 NOVEL INDAZOLE DERIVATIVE AND USE THEREOF TRIB2, YAP1, IDO2 IMPDH2 2393/4885IDO1 9/4885NISCH 4431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.